Highlights Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Real-time Estimate Cboe BZX Other stock markets 11:36:13 09/05/2024 pm IST			5-day change	1st Jan Change
9.44 ^USD	+1.29%		+12.04%	+248.15%

11/04	Sector Update: Health Care Stocks Softer Late Afternoon	MT
11/04	Top Midday Gainers	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Softer Late Afternoon	12/04	MT
Top Midday Gainers	11/04	MT
Sector Update: Health Care Stocks Decline Thursday Afternoon	11/04	MT
Eliem Therapeutics to Acquire Tenet Medicines; Launching Private Placement -- Eliem Shares Surge	11/04	MT
Top Premarket Gainers	11/04	MT
Eliem Therapeutics, Inc. entered into a definitive acquisition agreement to acquire Tenet Medicines, Inc.	11/04	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	07/23/07	AQ
Eliem Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	07/23/07	CI
Eliem Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	07/23/07	CI
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Results and Operations (form 10-Q)	14/22/14	AQ
Eliem Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Eliem Therapeutics, Inc. Provides Update on Pipeline Progress	05/22/05	CI
ELIEM THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Results and Operations (form 10-Q)	15/22/15	AQ
Eliem Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/22/15	CI
Eliem Therapeutics, Inc. Provides ETX-810 Program Update	02/22/02	CI
Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder	18/22/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Highlights

Filters